Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Women with hair loss have more androgen receptors in certain hair follicles.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Increased PPARGC1α relates to hair thinning in common baldness.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.